Alexandros Páris de Mesquita Ipácio

Alexandros Páris de Mesquita Ipácio

Auto-generated profile, based on publicly available information

Alexandros Páris de Mesquita Ipácio

State University of Maranhão Tocantine Region Imperatriz Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Pediatric Anesthesia
Verified
Journal Article
Open access
EWElizabet Taylor Pimenta Weba
Elizabet Taylor Pimenta Weba
GSGabriel Soares de Sousa
Gabriel Soares de Sousa
AIAlexandros Páris de Mesquita Ipácio
Alexandros Páris de Mesquita Ipácio
CFChristian Ken Fukunaga
Christian Ken Fukunaga
RSRafael Andrade Sampaio Silva
Rafael Andrade Sampaio Silva
BUBritta Sylvia von Ungern-Sternberg
Britta Sylvia von Ungern-Sternberg
Introduction: Lidocaine is widely used in pediatric anesthesia for airway topicalization to modulate undesirable airway and circulatory reflexes, yet its effectiveness remains unclear. Therefore, we aimed to perform a meta‐analysis evaluating the impact of topical lidocaine on respiratory adverse events in children undergoing airway management. Methods: PubMed, Embase, and Cochrane databases were systematically searched for studies comparing topical lidocaine with placebo, no intervention, or intravenous lidocaine for pediatric airway management. Statistical analysis was performed using R (version 4.4.1). Odds ratios (ORs) were used for binary outcomes and mean differences for continuous outcomes, with 95% confidence intervals (CIs) computed using a random‐effects model. Results: Fourteen randomized controlled trials comprising 1937 pediatric patients were included, of whom 917 (47%) received airway topicalization. In those receiving topical lidocaine, there was a significant reduction in the incidence of laryngospasm (OR 0.50; 95% CI 0.27 to 0.95; p = 0.033), desaturation (OR 0.49; 95% CI 0.25 to 0.98; p = 0.043), and sore throat (OR 0.31; 95% CI 0.16 to 0.58; p < 0.001). However, no significant differences were observed for bronchospasm (OR 0.50; 95% CI 0.11 to 2.35; p = 0.382), cough (OR 0.56; 95% CI 0.28 to 1.11; p = 0.099), severe cough (OR 1.30; 95% CI 0.18 to 9.51; p = 0.793), hoarseness (OR 1.41; 95% CI 0.17 to 11.96; p = 0.754), vomiting (OR 1.95; 95% CI 0.47 to 7.99; p = 0.355), and heart rate (beats/min) (MD 0.08; 95% CI −6.31 to 6.47; p = 0.98). Conclusion: Our findings suggest that topical lidocaine may reduce the incidence of undesirable airway reflexes such as laryngospasm, desaturation, and sore throat in children undergoing airway management. However, its benefit for other perioperative respiratory adverse events requires further investigation, especially in high‐risk populations. Trial Registration: PROSPERO registration number: CRD42024614863

6 February 2025 in Revista de Gestão Social e Ambiental
Verified
Journal Article
Open access
PDF file
AIAlexandros Páris de Mesquita Ipácio
Alexandros Páris de Mesquita Ipácio
EWElizabet Taylor Pimenta Weba
Elizabet Taylor Pimenta Weba
EMEslainy Xavier Matos
Eslainy Xavier Matos
GSGuilherme Eduardo Nolêto de Sousa Santana
Guilherme Eduardo Nolêto de Sousa Santana
JMJudith Carneiro Maciel
Judith Carneiro Maciel
MAMatheus Alves
Matheus Alves
Objective: Compare the variables of breast cancer patients in Maranhão and Brazil between 2012 and 2022. Theoretical Framework: Breast cancer is the most diagnosed neoplasm among women and, in Brazil, it is the leading cause of cancer-related deaths. A healthy lifestyle minimizes the chances of developing the disease, but does not eliminate them. Treatment varies according to the stage and type of tumor, encompassing traditional options and advancements such as genetic mapping and targeted therapies, while public policies promote early diagnosis and screening. Method: Cross-sectional, retrospective, descriptive epidemiological study with a quantitative approach, based on secondary data from the Oncology Observatory, focusing on variables such as age group, type of treatment, procedures performed, mortality from breast cancer, and SUS investments by procedure groups. Data were analyzed using descriptive statistics. Results and Discussion: The results revealed an increase in breast cancer incidence in Maranhão and Brazil, with rates ranging from 51.83 to 61.78 cases per 100,000 women in Brazil and from 13.35 to 23.53 in Maranhão. A higher proportion of young patients receiving outpatient treatment was observed in Maranhão, highlighting regional inequalities. Adjuvant chemotherapy was the most performed procedure, although there is underutilization of complementary services in the state. The lack of mortality data in Maranhão limits understanding of the disease's impact, emphasizing the need for monitoring strategies.